Researchers are working to improve the classification and evaluation of brca2 variants, with some studies focusing on high-throughput functional evaluation and others on combining multiplexed assays for enhanced classification. The efforts aim to advance cancer genetic testing and improve prevention and patient treatment. The scope of the research appears to extend beyond brca2 to also include brca1 and other genes, with various methods being explored for functional validation and assessment of protein variants.